SEPT9 methylation as a diagnostic and predictive biomarker in the progression of ductal carcinoma in situ to invasive breast cancer
Crossref DOI link: https://doi.org/10.1038/s41598-025-25096-z
Published Online: 2025-11-21
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guo, Yuan
Zhou, Xiaoli
Xu, Haoran
Wang, Gengfang
Text and Data Mining valid from 2025-11-21
Version of Record valid from 2025-11-21
Article History
Received: 24 June 2025
Accepted: 17 October 2025
First Online: 21 November 2025
Declarations
:
: The authors declare no competing interests.